TIFFANY ROGERS: Open Payments
NPI 1144957150 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 11 payments from 8 companies in 2025. Trend: 2023 $119 · 2024 $105 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Actelion Pharmaceuticals US, Inc. | 1 | $33 |
| Grifols USA, LLC | 1 | $33 |
| GENZYME CORPORATION | 2 | $29 |
| Verona Pharma, Inc. | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Shionogi Inc | 1 | $14 |
Products named: OPSYNVI, Prolastin-C Liquid, KEYTRUDA, DUPIXENT, WINREVAIR, LIVTENCITY, Ohtuvayre, Xolair.
Industry payments across AZ — which companies pay providers there.
